Replay

Patricia Réant

Patricia Réant

La déformation longitudinale facteur prédictive indépendant de la survie et de la réponse au traitement chez les patients atteints d'amylose AL systémique

Damien Guijarro

Damien Guijarro

Importance clinique de l'infiltration auriculaire tardive dans l'amylose transthyrétine cardiaque

Thibaud DAMY

Thibaud DAMY

Prévalence de la cardiomyopathie amyloïde à transthyrétine
dans l'insuffisance cardiaque avec fraction d'éjection préservée". Les dernières données

Marc-Antoine DELBARRE

-

Olivier Lairez

Olivier Lairez

Ventricular tachyarrhythmias and sudden cardiac death in light chain amyloidosis a clash of cardio

Silvia OGHINA

Silvia OGHINA

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation

Olivier HUTTIN

Olivier HUTTIN

Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.

Benjamin ALOS

Benjamin ALOS

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy

Martin NICOL

Martin NICOL

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation

Lisa GREEN

Lisa GREEN

Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies

Denis DUBOC

Denis DUBOC

Durable mechanical circulatory Support in Patients with Amyloid cardiomyopathy

Arnault GALAT

Arnault GALAT

Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis

 Emmanuelle BERTHELOT

Emmanuelle BERTHELOT

Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

Damien LEGALLOIS

Damien LEGALLOIS

Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis

 Jean-Christophe EICHER

Jean-Christophe EICHER

The impact of patients with cardiac amyloidosis in HFpEF Trials

Antoine JOBBE-DUVA

Antoine JOBBE-DUVA

Identifying Cardiac Amyloid in Aortic Stenosis

Damien GUIJARRO

Damien GUIJARRO

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan in transthyretin wild-type cardiac amyloidosis

Erwan DONAL

Erwan DONAL

Prevalence and Outcomes of Concomitant Aortic Stenosis and cardiac amyloidosi

Olivier LAIREZ

Olivier LAIREZ

Flobertaben for differential Diagnosis Among Cardiac Immunoglobulin light Chain

Thibaud DAMY

Thibaud DAMY

Diseases progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.